Rgds Peptide Conjugation
Rgds Peptide Conjugation - Related Videos
04:59
Evaluating the Intracellular Distribution of Virus-Derived Peptide-Modified Antibody Conjugates
0 Views •
2025
This video demonstrates the process of assessing the intracellular distribution of virus-derived peptide-modified antibody conjugates using confocal microscopy. The viral-derived nuclear localization sequence directs antibody-conjugates within the cytoplasm, confirmed through immunostaining and fluorescence measurement.
11:05
Capillary Electrophoresis to Monitor Peptide Grafting onto Chitosan Films in Real Time
0 Views •
Cited by 1 •
2016
Free solution capillary electrophoresis is a fast, cheap and robust analytical method that enables the quantitative monitoring of chemical reactions in real time. Its utility for rapid, convenient and precise analysis is demonstrated here through analysis of covalent peptide grafting onto chitosan films for improved cell adhesion.
11:58
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
0 Views •
Cited by 5 •
2018
Viral-derived peptides coupled to antibody-conjugates (ACs) is an approach gaining momentum due to the potential of delivering molecular payloads with increased tumor cell accumulation. Utilizing common methods to evaluate peptide conjugation, AC and payload intracellular accumulation, and tumor targeting, this protocol helps researchers during the key initial development phases.
04:00
Immunoaffinity Based Extraction of Ubiquitinylated Peptides: A Technique to Selectively Extract Ubiquitin Tagged Peptides from Purified Peptide Fractions
0 Views •
2023
This video describes a method to extract and purify ubiquitinylated peptides containing remnant di-glycine peptides from a complex peptide mixture. The presented method may help in identifying original ubiquitination sites in the protein.
02:50
Conjugated Proteins
0 Views •
2020
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties. Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
FAQs
Linker chemistry determines how the peptide is attached, while orientation influences whether the RGD sequence remains accessible to cell-surface integrins. A stable linkage can preserve the conjugate during use, but attachment must also avoid masking the recognition motif. These design choices directly affect integrin engagement and therefore the ability of a modified material to support cell adhesion or signaling.
Peptide density changes how many RGD recognition sites are presented across a surface or within a biomaterial. That presentation can alter the likelihood of integrin engagement and the resulting cellular response. Density should therefore be treated as a design variable rather than simply maximized: its value is meaningful only together with linker chemistry, orientation, and the intended use of the modified polymer, hydrogel, nanoparticle, or scaffold.
The carrier determines the setting in which the RGD motif is presented and the biological function the conjugate is designed to support. Polymers and hydrogels can provide biomaterial contexts, scaffolds can support tissue engineering, and nanoparticles can support delivery. Thus, carrier selection links conjugation chemistry to the intended cellular or tissue-level outcome.
A basic workflow begins by identifying compatible functional groups on the peptide and carrier, then forming a covalent chemical linkage between them. The resulting construct should be considered against two connected design goals: linkage stability and preservation of RGD accessibility. This workflow applies whether the carrier is a molecule, polymer, nanoparticle, hydrogel, or tissue-engineering scaffold.
It is useful when a material needs to promote cell attachment or direct a cellular response through integrin recognition. Bioengineers can incorporate the conjugate into polymers, hydrogels, nanoparticles, or tissue-engineering scaffolds, depending on the intended platform. The same strategy can also support delivery to integrin-expressing tissues, extending its relevance beyond surface adhesion alone.
In tissue engineering, RGD-modified scaffolds can provide integrin-recognizable cues that encourage cell attachment and influence signaling. In delivery systems, conjugated nanoparticles can use the same recognition principle to interact selectively with tissues that express the relevant integrins. These applications illustrate how one chemical modification can connect material design with cell behavior and tissue-specific targeting.